Clinical trial
NK-1 Antagonism of SLV317 in Humans
NCT00160862 · Heidelberg University, Other · Completed
Key facts
| NCT number | NCT00160862 |
|---|---|
| Title | NK-1 Antagonism of SLV317 in Humans |
| Official title | A Randomised, Double-Blind, Placebo-Controlled, Crossover Study to Determine the Effect of a Single Oral Dose of SLV 317 on Substance P-Induced Venodilation in the Hand Vein of Healthy Male Volunteers |
| Lead sponsor | Heidelberg University, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | SLV317 |
| Enrollment | 18 |
| Start date | May 1, 2003 |
| Completion | Nov 1, 2003 |
| First posted | Sep 12, 2005 |
| Last update posted | Sep 12, 2005 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: